Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT

Sana Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-93.8M -49.39M -49.07M -59.92M -50.29M -107.47M -88.12M 984K -114M -82.12M -80.44M -85.12M -72.47M -31.45M -110.73M -83.26M 18.68M -180.62M
Depreciation & Amortization
2.86M 3.65M 5.69M 4.06M 3.9M 3.75M 7.54M 4.5M 4.45M 4.35M 4.2M 4.02M 3.8M 3.61M 3.33M 2.88M 2.61M 2.25M
Stock-Based Compensation
6.63M 7.02M 6.44M 10.77M 11.38M 9.09M 7.93M 9M 9.85M 8.75M 10.59M 10.08M 9.91M 7.75M 7.31M 5.95M 4.94M 4.16M
Other Working Capital
-4.59M -6.63M 1.99M 163K 1.68M -6.4M 11.58M 2.9M 13.56M -10.45M -4.5M 10.59M 5.67M -5.28M 126K 3.9M 10.78M -4.74M
Other Non-Cash Items
54.58M 919K -14.49M -6.38M -7.37M 54.11M 34.79M -83.21M 26.91M 561K -4.82M -5.85M -17.14M -54.27M -8.48M 18.28M -75.59M 127.44M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -24.35M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-3.37M -10.86M 4.27M -344K 2.35M -7.46M 10.24M 5.18M 14M -10.81M -5.59M 12.07M 4.42M -3.36M -1.54M 5.67M 8.81M -3.14M
Operating Cash Flow
-33.1M -48.66M -47.16M -51.82M -58.54M -65.63M -51.96M -63.55M -58.8M -79.27M -76.07M -64.8M -71.48M -77.71M -110.1M -50.49M -40.56M -49.91M
Capital Expenditures
112K -136K -436K -4.09M -13.06M -15.85M -14.05M -2.23M -1.58M -2.18M -4.6M -4.35M -4.39M -7.53M -5.2M -8.06M -10.16M -6.44M
Cash Acquisitions
382K 253K n/a n/a n/a n/a -29.36K -53.58K -44.2K n/a n/a -36.21K -82.12K n/a n/a n/a n/a n/a
Purchase of Investments
n/a -1.68M -13.08M -35.97M -62.63M -114.39M -26.13M -60.35M -50.84M -20.43M -15.11M -17.62M -20.29M -25.68M -76.95M -248.89M -120.74M -44.81M
Sales Maturities Of Investments
7.19M 18.17M 60.6M 81.84M 81.5M 53.01M 55.48M 113.93M 95.04M 85.33M 108.14M 53.83M 102.41M 45.75M 13.06M 71.05M 95.57M 100.34M
Other Investing Acitivies
n/a n/a n/a n/a n/a -61.38M 29.36K 53.58K 44.2K n/a n/a 36.21K 82.12K 20.08M -4.57M -177.84M -25.17M 55.53M
Investing Cash Flow
7.68M 16.6M 47.09M 41.77M 5.82M -77.23M 15.31M 51.35M 42.63M 62.73M 88.43M 31.86M 77.73M 12.54M -73.66M -185.9M -35.32M 49.09M
Debt Repayment
-86K -85K -56K 172K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
60K -60K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
60K 1.13M 181.7M 1.94M 11.07M 4.93M n/a 192K 2.49M 236K 1.18M n/a n/a n/a 3.12M 1.6M 333K 298K
Financial Cash Flow
561K 982K 643K 2.08M 10.63M 186.4M 1.72M 187K 29.5M 236K 1.06M 1.62M 1.58M 652K 3.12M 1.6M 333K 626.7M
Net Cash Flow
-24.86M -31.07M 570K -7.96M -42.1M 43.54M -34.93M -12.02M 13.33M -16.31M 13.42M -31.32M 7.83M -64.51M -180.64M -234.79M -75.55M 625.88M
Free Cash Flow
-32.99M -48.79M -47.6M -55.91M -71.6M -81.48M -66M -65.78M -60.38M -81.45M -80.67M -69.15M -75.87M -85.24M -115.3M -58.55M -50.71M -56.35M